Author

Debasis Nayak

The Ohio State UniversityORCID 0000-0003-3333-1300Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Research Focus:chromatin & epigenetic regulation· 1

Frequent Co-Authors

Jaimie S. GrayiD· 2 shared Mark D. LongiD· 2 shared Moray J. CampbelliD· 2 shared Sajad A. WaniiD· 2 shared Shahid HussainiD· 2 shared Arindam MaitraiD· 1 shared C Bennet· 1 shared Christopher Charles CossiD· 1 shared

Activity by Year

2023-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Jaimie S. GrayORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Molecular BiologybioRxivPreprintOct 16, 2026

Interleukin-4 suppresses TIMP-2 transcription during endometriosis: Allele-specific regulation of the TIMP-2 -418G/C promoter by SP1

Susmita Saha, Supratim Ghosh, Tapasi Roy…·Snehasikta Swarnakar

This study identifies an IL-4-SP1-TIMP-2 regulatory axis that contributes to ECM dysregulation in endometriosis and shows the TIMP-2 -418G/C promoter polymorphism affects cytokine-mediated transcription.

DOI 10.64898/2026.10.15.759364

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintDec 15, 2023

Epigenetic disruption of the RARγ complex impairs its function to bookmark AR enhancer interactions required for enzalutamide sensitivity in prostate cancer

Sajad A. Wani, Shahid Hussain, Jaimie S. Gray…·Moray J. Campbell

This study identifies RARγ's role in bookmarking AR enhancer interactions in prostate cancer, showing its impact on enzalutamide sensitivity and lineage plasticity.

1 citation

humanChIP-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintNov 15, 2023

The MYC axis in advanced prostate cancer is impacted through concurrent targeting of ERβ and AR using a novel ERβ-selective ligand alongside Enzalutamide

Jaimie S. Gray, Sajad A. Wani, Shahid Hussain…·Moray J. Campbell

This study shows that combining a novel ERβ ligand with Enzalutamide reduces MYC signaling and growth in advanced prostate cancer.

4 citations

humanbulk RNA-seq

𝕏 PostBluesky